Teikyo University
Haruko Tashiro, a distinguished researcher at Teikyo University, has made remarkable contributions to the development of CAR T cell therapies for AML including engineering CAR T cell targeting CLL-1. Together with researchers from Chulalongkorn University, they aim to combine their expertise and develop CAR T cell therapy for AML patients through knowledge exchange and scientific discussions.
Haruko Tashiro
Qualification
MD, PhD
Title and Affiliation
Associate Professor
- Department of Hematology/Oncology, Teikyo University School of Medicine, Tokyo
- Member
- The Japanese Society of Hematology
- The Japan Society for Hematopoietic Cell Transplantation
- The Japan Society for Transfusion Medicine and Cell Therapy
Email: [email protected]
Link: https://www.researchgate.net/profile/Haruko-Tashiro